Hudson Technologies (NASDAQ:HDSN) has been upgraded from a buy rating to a strong-buy rating by Wall Street Zen, according to a research note published on Monday....
Corcept Therapeutics Incorporated (NASDAQ:CORT) has received an average consensus rating of “Buy” from five brokerage firms currently covering the stock, according to Marketbeat Ratings. Analysts have...
Corcept Therapeutics Incorporated (NASDAQ:CORT) has received a consensus rating of “Buy” from the five brokerage firms currently covering its stock, according to a report by Marketbeat...